Axa’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Axa’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,100	Closed	-$249K	–	1362
2020 Q4	$249K	Buy	+10,100	New	+$335K	﹤0.01%	1157
2019 Q2	–	Sell	-29,755	Closed	-$3.33M	–	1380
2019 Q1	$3.33M	Hold	29,755	–	–	0.01%	752
2018 Q4	$3M	Hold	29,755	–	–	0.01%	731
2018 Q3	$3.76M	Buy	+29,755	New	+$3.15M	0.01%	745
2018 Q1	–	Sell	-24,632	Closed	-$1.44M	–	1435
2017 Q4	$1.44M	Sell	24,632 -16	-0.1%	-$1.01K	0.01%	924
2017 Q3	$1.43M	Sell	24,648 -64,021	-72%	-$6.9M	0.01%	887
2017 Q2	$10.7M	Sell	88,669 -3,301	-4%	-$382K	0.05%	408
2017 Q1	$10.4M	Sell	91,970 -2,819	-3%	-$329K	0.05%	409
2016 Q4	$10.3M	Buy	94,789 +16,290	+21%	+$1.94M	0.05%	400
2016 Q3	$12.9M	Sell	78,499 -4,864	-6%	-$767K	0.06%	333
2016 Q2	$11.9M	Sell	83,363 -11,101	-12%	-$1.62M	0.05%	344
2016 Q1	$12.1M	Sell	94,464 -1,526	-2%	-$180K	0.05%	351
2015 Q4	$14.3M	Buy	95,990 +10,981	+13%	+$1.86M	0.06%	296
2015 Q3	$14.1M	Buy	85,009 +16,690	+24%	+$3.67M	0.06%	305
2015 Q2	$16.5M	Hold	68,319	–	–	0.07%	288
2015 Q1	$19.3M	Buy	68,319 +7,674	+13%	+$1.66M	0.08%	268
2014 Q4	$9.46M	Buy	60,645 +50,645	+506%	+$9.35M	0.04%	400
2014 Q3	$2.37M	Buy	+10,000	New	+$2.55M	0.01%	703

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Axa's ICPT Position: Q1 2021 in Review

Axa sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 10,100 shares — an estimated $249K sold.

Axa first reported a position in ICPT in Q3 2014 and held it in 18 quarters. The position peaked at $19.3M in Q1 2015. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Axa reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Axa sold 10,100 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $249K.
Axa first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 18 quarters.
Axa's Intercept Pharmaceuticals, Inc. position peaked at $19.3M in Q1 2015.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.